Cargando…
Structural and functional findings in patients with moderate diabetic retinopathy
PURPOSE: To evaluate structural and functional ocular changes in patients with type 2 diabetes mellitus (DM2) and moderate diabetic retinopathy (DR) without apparent diabetic macular edema (DME) assessed by optical coherence tomography (OCT) and microperimetry. METHODS: This was a single-center cros...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589761/ https://www.ncbi.nlm.nih.gov/pubmed/34264395 http://dx.doi.org/10.1007/s00417-021-05277-y |
_version_ | 1784598801044996096 |
---|---|
author | Boned-Murillo, A. Diaz-Barreda, M. D. Ferreras, A. Bartolomé-Sesé, I. Orduna-Hospital, E. Montes-Rodríguez, P. Ascaso, J. Pinilla, Isabel |
author_facet | Boned-Murillo, A. Diaz-Barreda, M. D. Ferreras, A. Bartolomé-Sesé, I. Orduna-Hospital, E. Montes-Rodríguez, P. Ascaso, J. Pinilla, Isabel |
author_sort | Boned-Murillo, A. |
collection | PubMed |
description | PURPOSE: To evaluate structural and functional ocular changes in patients with type 2 diabetes mellitus (DM2) and moderate diabetic retinopathy (DR) without apparent diabetic macular edema (DME) assessed by optical coherence tomography (OCT) and microperimetry. METHODS: This was a single-center cross-sectional descriptive study for which 75 healthy controls and 48 DM2 patients with moderate DR were included after applying exclusion criteria (one eye per patient was included). All eyes underwent a complete ophthalmic examination (axial length, macular imaging with swept-source OCT, and MAIA microperimetry). Macular thicknesses, ganglion cell complex (GCC) thicknesses, and central retinal sensitivity were compared between groups, and the relationships between the OCT and microperimetry parameters were evaluated. RESULTS: Macular thickness was similar in both groups (242.17 ± 35.0 in the DM2 group vs 260.64 ± 73.9 in the control group). There was a diminution in the parafoveal area thickness in the DM2 group in the GCC complex. Retinal sensitivity was reduced in all sectors in the DM2 group. The central global value was 24.01 ± 5.7 in the DM2 group and 27.31 ± 2.7 in the control group (p < 0.001). Macular integrity was 80.89 ± 26.4 vs 64.70 ± 28.3 (p < 0.001) and total mean threshold was 23.90 ± 4.9 vs 26.48 ± 2.6 (p < 0.001) in the DM2 and control group, respectively. Moderate correlations were detected between the central sector of MAIA microperimetry and retina total central thickness (− 0.347; p = 0.0035). Age, visual acuity, and hemoglobin A1c levels also correlated with retinal sensitivity. CONCLUSION: Macular GCC thickness and central retinal sensitivity were reduced in patients with moderate DR without DME, suggesting the presence of macular neurodegeneration. [Image: see text] |
format | Online Article Text |
id | pubmed-8589761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85897612021-11-15 Structural and functional findings in patients with moderate diabetic retinopathy Boned-Murillo, A. Diaz-Barreda, M. D. Ferreras, A. Bartolomé-Sesé, I. Orduna-Hospital, E. Montes-Rodríguez, P. Ascaso, J. Pinilla, Isabel Graefes Arch Clin Exp Ophthalmol Retinal Disorders PURPOSE: To evaluate structural and functional ocular changes in patients with type 2 diabetes mellitus (DM2) and moderate diabetic retinopathy (DR) without apparent diabetic macular edema (DME) assessed by optical coherence tomography (OCT) and microperimetry. METHODS: This was a single-center cross-sectional descriptive study for which 75 healthy controls and 48 DM2 patients with moderate DR were included after applying exclusion criteria (one eye per patient was included). All eyes underwent a complete ophthalmic examination (axial length, macular imaging with swept-source OCT, and MAIA microperimetry). Macular thicknesses, ganglion cell complex (GCC) thicknesses, and central retinal sensitivity were compared between groups, and the relationships between the OCT and microperimetry parameters were evaluated. RESULTS: Macular thickness was similar in both groups (242.17 ± 35.0 in the DM2 group vs 260.64 ± 73.9 in the control group). There was a diminution in the parafoveal area thickness in the DM2 group in the GCC complex. Retinal sensitivity was reduced in all sectors in the DM2 group. The central global value was 24.01 ± 5.7 in the DM2 group and 27.31 ± 2.7 in the control group (p < 0.001). Macular integrity was 80.89 ± 26.4 vs 64.70 ± 28.3 (p < 0.001) and total mean threshold was 23.90 ± 4.9 vs 26.48 ± 2.6 (p < 0.001) in the DM2 and control group, respectively. Moderate correlations were detected between the central sector of MAIA microperimetry and retina total central thickness (− 0.347; p = 0.0035). Age, visual acuity, and hemoglobin A1c levels also correlated with retinal sensitivity. CONCLUSION: Macular GCC thickness and central retinal sensitivity were reduced in patients with moderate DR without DME, suggesting the presence of macular neurodegeneration. [Image: see text] Springer Berlin Heidelberg 2021-07-15 2021 /pmc/articles/PMC8589761/ /pubmed/34264395 http://dx.doi.org/10.1007/s00417-021-05277-y Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Retinal Disorders Boned-Murillo, A. Diaz-Barreda, M. D. Ferreras, A. Bartolomé-Sesé, I. Orduna-Hospital, E. Montes-Rodríguez, P. Ascaso, J. Pinilla, Isabel Structural and functional findings in patients with moderate diabetic retinopathy |
title | Structural and functional findings in patients with moderate diabetic retinopathy |
title_full | Structural and functional findings in patients with moderate diabetic retinopathy |
title_fullStr | Structural and functional findings in patients with moderate diabetic retinopathy |
title_full_unstemmed | Structural and functional findings in patients with moderate diabetic retinopathy |
title_short | Structural and functional findings in patients with moderate diabetic retinopathy |
title_sort | structural and functional findings in patients with moderate diabetic retinopathy |
topic | Retinal Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589761/ https://www.ncbi.nlm.nih.gov/pubmed/34264395 http://dx.doi.org/10.1007/s00417-021-05277-y |
work_keys_str_mv | AT bonedmurilloa structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT diazbarredamd structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT ferrerasa structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT bartolomesesei structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT ordunahospitale structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT montesrodriguezp structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT ascasoj structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy AT pinillaisabel structuralandfunctionalfindingsinpatientswithmoderatediabeticretinopathy |